658. Oral Vancomycin Taper for First Occurrence of Clostridioides difficile Compared to Standard of Care: An Observational Retrospective Matched Cohort Study

BACKGROUND: Clostridioides difficile infection (CDI) recurrence rates may be reduced with fidaxomicin, but financial barriers can limit access. Tapered and/or pulsed oral vancomycin is recommended in patients with recurrent CDI, however there is currently limited data for use in treating initial CDI...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, Sarah E, Swingler, Elena A, Song, Matthew, Wilde, Ashley M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677723/
http://dx.doi.org/10.1093/ofid/ofad500.721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677723/
http://dx.doi.org/10.1093/ofid/ofad500.721

Ejemplares similares